Your browser doesn't support javascript.
loading
Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study Group.
Sakai, Mari; Miyazaki, Yasushi; Matsuo, Emi; Moriuchi, Yukiyoshi; Hata, Tomoko; Fukushima, Takuya; Imaizumi, Yoshitaka; Imanishi, Daisuke; Taguchi, Jun; Iwanaga, Masako; Tsushima, Hideki; Inoue, Yoriko; Takasaki, Yumi; Tsuchiya, Takeshi; Komoda, Minori; Ando, Koji; Horio, Kensuke; Moriwaki, Yuji; Tominaga, Shinya; Itonaga, Hidehiro; Nagai, Kazuhiro; Tsukasaki, Kunihiro; Tsutsumi, Chizuko; Sawayama, Yasushi; Yamasaki, Reishi; Ogawa, Daisuke; Kawaguchi, Yasuhisa; Ikeda, Shuichi; Yoshida, Shinichiro; Onimaru, Yasuyuki; Tawara, Masayuki; Atogami, Sunao; Koida, Satoshi; Joh, Tatsuro; Yamamura, Masaomi; Matsuo, Yuji; Soda, Hisashi; Nonaka, Hiroaki; Jinnai, Itsuro; Kuriyama, Kazutaka; Tomonaga, Masao.
Afiliação
  • Sakai M; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Miyazaki Y; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. y-miyaza@nagasaki-u.ac.jp.
  • Matsuo E; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Moriuchi Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Hata T; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Fukushima T; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Imaizumi Y; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Imanishi D; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Taguchi J; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Iwanaga M; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Tsushima H; Nagasaki CML Study Group, Nagasaki, Japan.
  • Inoue Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Takasaki Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Tsuchiya T; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Komoda M; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Ando K; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Horio K; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Moriwaki Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Tominaga S; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Itonaga H; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Nagai K; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Tsukasaki K; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Tsutsumi C; Nagasaki CML Study Group, Nagasaki, Japan.
  • Sawayama Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Yamasaki R; Nagasaki CML Study Group, Nagasaki, Japan.
  • Ogawa D; Nagasaki CML Study Group, Nagasaki, Japan.
  • Kawaguchi Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Ikeda S; Nagasaki CML Study Group, Nagasaki, Japan.
  • Yoshida S; Nagasaki CML Study Group, Nagasaki, Japan.
  • Onimaru Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Tawara M; Nagasaki CML Study Group, Nagasaki, Japan.
  • Atogami S; Nagasaki CML Study Group, Nagasaki, Japan.
  • Koida S; Nagasaki CML Study Group, Nagasaki, Japan.
  • Joh T; Nagasaki CML Study Group, Nagasaki, Japan.
  • Yamamura M; Nagasaki CML Study Group, Nagasaki, Japan.
  • Matsuo Y; Nagasaki CML Study Group, Nagasaki, Japan.
  • Soda H; Nagasaki CML Study Group, Nagasaki, Japan.
  • Nonaka H; Nagasaki CML Study Group, Nagasaki, Japan.
  • Jinnai I; Nagasaki CML Study Group, Nagasaki, Japan.
  • Kuriyama K; Nagasaki CML Study Group, Nagasaki, Japan.
  • Tomonaga M; Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
Int J Hematol ; 89(3): 319-325, 2009 Apr.
Article em En | MEDLINE | ID: mdl-19266256
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Tamanho Corporal / Antineoplásicos Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2009 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Tamanho Corporal / Antineoplásicos Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2009 Tipo de documento: Article